Martin Shkreli, the pharmaceutical manager and possible goblin-kobold hybrid best known for acquiring the rights to and jacking up the price of HIV drug Daraprim before composing seven years in a cell for securities forgery, is trying to get out of prison by claiming he might be of use in the fight against the novel…
Read more: gizmodo.com
Recent Comments